Regulation of Erythrocyte Cation and Water Content in Sickle Cell Anemia-Reference-Cited by-同舟云学术

Regulation of Erythrocyte Cation and Water Content in Sickle Cell Anemia

Published:1986-04-18 Issue:4748 Volume:232 Page:388-390
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Brugnara Carlo¹,Bunn H. Franklin²,Tosteson Daniel C.¹

Affiliation:

1. Department of Physiology and Biophysics, Harvard Medical School, Boston, MA 02115.

2. Laboratory of the Howard Hughes Medical Institute, Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference21 articles.

1. BERKOWITZ, L.R., PASSIVE SODIUM AND POTASSIUM MOVEMENTS IN SICKLE ERYTHROCYTES, AMERICAN JOURNAL OF PHYSIOLOGY 249: C208 (1985).

2. BERKOWITZ, L.R., EFFECTS OF CETIEDIL ON MONO-VALENT CATION PERMEABILITY IN THE ERYTHROCYTE - AN EXPLANATION FOR THE EFFICACY OF CETIEDIL IN THE TREATMENT OF SICKLE-CELL-ANEMIA, BLOOD CELLS 8: 283 (1982).

3. BERKOWITZ, L.R., EFFECT OF CETIEDIL, AN INVITRO ANTISICKLING AGENT, ON ERYTHROCYTE-MEMBRANE CATION PERMEABILITY, JOURNAL OF CLINICAL INVESTIGATION 68: 1215 (1981).

4. BOOKCHIN, R.M., DETERMINANTS OF RED-CELL SICKLING - EFFECTS OF VARYING PH AND OF INCREASING INTRACELLULAR HEMOGLOBIN CONCENTRATION BY OSMOTIC SHRINKAGE, JOURNAL OF LABORATORY AND CLINICAL MEDICINE 87: 597 (1976).

5. BRUGNARA, C, REGULATION OF CATION CONTENT AND CELL-VOLUME IN HEMOGLOBIN ERYTHROCYTES FROM PATIENTS WITH HOMOZYGOUS HEMOGLOBIN-C DISEASE, JOURNAL OF CLINICAL INVESTIGATION 75: 1608 (1985).

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating sheep hemoglobins with MD simulations as an animal model for sickle cell disease;Scientific Reports;2024-01-02

2. Le globule rouge drépanocytaire : données fonctionnelles;La Revue de Médecine Interne;2023-11

3. Emerging drug targets for sickle cell disease: shedding light on new knowledge and advances at the molecular level;Expert Opinion on Therapeutic Targets;2023-02-01

4. Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease;Proceedings of the National Academy of Sciences;2022-09-26

5. Moringa oleifera extract regulates the expression of some sickle cell related genes in normal Wistar rats;Journal of Pharmacy & Pharmacognosy Research;2022-09-01